1
|
Zidane M, Truong T, Lesueur F, Xhaard C, Cordina-Duverger E, Boland A, Blanché H, Ory C, Chevillard S, Deleuze JF, Souchard V, Ren Y, Zemmache MZ, Canale S, Borson-Chazot F, Schvartz C, Mariné Barjoan E, Guizard AV, Laurent-Puig P, Mulot C, Guibon J, Karimi M, Schlumberger M, Adjadj E, Rubino C, Guenel P, Cazier JB, de Vathaire F. Role of DNA Repair Variants and Diagnostic Radiology Exams in Differentiated Thyroid Cancer Risk: A Pooled Analysis of Two Case-Control Studies. Cancer Epidemiol Biomarkers Prev 2021; 30:1208-1217. [PMID: 33827984 DOI: 10.1158/1055-9965.epi-20-1142] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2020] [Revised: 11/12/2020] [Accepted: 03/29/2021] [Indexed: 11/16/2022] Open
Abstract
BACKGROUND Given the increased use and diversity of diagnostic procedures, it is important to understand genetic susceptibility to radiation-induced thyroid cancer. METHODS On the basis of self-declared diagnostic radiology examination records in addition to existing literature, we estimated the radiation dose delivered to the thyroid gland from diagnostic procedures during childhood and adulthood in two case-control studies conducted in France. A total of 1,071 differentiated thyroid cancer (DTC) cases and 1,188 controls from the combined studies were genotyped using a custom-made Illumina OncoArray DNA chip. We focused our analysis on variants in genes involved in DNA damage response and repair pathways, representing a total of 5,817 SNPs in 571 genes. We estimated the OR per milli-Gray (OR/mGy) of the radiation dose delivered to the thyroid gland using conditional logistic regression. We then used an unconditional logistic regression model to assess the association between DNA repair gene variants and DTC risk. We performed a meta-analysis of the two studies. RESULTS The OR/mGy was 1.02 (95% confidence interval, 1.00-1.03). We found significant associations between DTC and rs7164173 in CHD2 (P = 5.79 × 10-5), rs6067822 in NFATc2 (P = 9.26 × 10-5), rs1059394 and rs699517 both in ENOSF1/THYS, rs12702628 in RPA3, and an interaction between rs7068306 in MGMT and thyroid radiation doses (P = 3.40 × 10-4). CONCLUSIONS Our results suggest a role for variants in CDH2, NFATc2, ENOSF1/THYS, RPA3, and MGMT in DTC risk. IMPACT CDH2, NFATc2, ENOSF1/THYS, and RPA3 have not previously been shown to be associated with DTC risk.
Collapse
Affiliation(s)
- Monia Zidane
- INSERM, Centre for Research in Epidemiology and Population Health (CESP), 94800 Villejuif, France
- Université Paris-Sud Orsay, Villejuif, France
- Gustave Roussy, Villejuif, France
| | - Thérèse Truong
- INSERM, Centre for Research in Epidemiology and Population Health (CESP), 94800 Villejuif, France
- Université Paris-Sud Orsay, Villejuif, France
- Gustave Roussy, Villejuif, France
| | - Fabienne Lesueur
- Inserm, U900, Institut Curie, Université PSL, Mines ParisTech, Paris, France
| | - Constance Xhaard
- INSERM Centre d'Investigation Clinique CIC-P 1433, CHRU Nancy, France
- INSERM U1116, FCRIN INI-CRCT, Lorraine Université, Nancy, France
| | - Emilie Cordina-Duverger
- INSERM, Centre for Research in Epidemiology and Population Health (CESP), 94800 Villejuif, France
- Université Paris-Sud Orsay, Villejuif, France
- Gustave Roussy, Villejuif, France
| | - Anne Boland
- Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France
| | - Hélène Blanché
- Fondation Jean Dausset-CEPH (Centre Etude du Polymorphisme Humain), Paris, France
- Laboratory of Excellence GENMED (Medical Genomics)
| | - Catherine Ory
- CEA, Direction de la Recherche Fondamentale, Institut de Biologie François Jacob, iRCM, SREIT, Laboratoire de Cancérologie Expérimentale (LCE), Université Paris-Saclay, Fontenay-aux-Roses, France
| | - Sylvie Chevillard
- CEA, Direction de la Recherche Fondamentale, Institut de Biologie François Jacob, iRCM, SREIT, Laboratoire de Cancérologie Expérimentale (LCE), Université Paris-Saclay, Fontenay-aux-Roses, France
| | - Jean-François Deleuze
- Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France
- Fondation Jean Dausset-CEPH (Centre Etude du Polymorphisme Humain), Paris, France
- Laboratory of Excellence GENMED (Medical Genomics)
| | - Vincent Souchard
- INSERM, Centre for Research in Epidemiology and Population Health (CESP), 94800 Villejuif, France
- Université Paris-Sud Orsay, Villejuif, France
- Gustave Roussy, Villejuif, France
| | - Yan Ren
- INSERM, Centre for Research in Epidemiology and Population Health (CESP), 94800 Villejuif, France
- Université Paris-Sud Orsay, Villejuif, France
- Gustave Roussy, Villejuif, France
| | - Mohammed Zakarya Zemmache
- INSERM, Centre for Research in Epidemiology and Population Health (CESP), 94800 Villejuif, France
- Université Paris-Sud Orsay, Villejuif, France
- Gustave Roussy, Villejuif, France
| | | | - Françoise Borson-Chazot
- Rhône-Alpes Thyroid Cancer Registry, Cancer Research Center of Lyon (UMR INSERM 1052, CNRS 5286), RTH Laennec Faculty of Medicine, University of Lyon, Lyon
| | - Claire Schvartz
- Thyroid Cancer Registry of Champagne-Ardennes, Institut Jean Godinot, Reims, Cancer Registry of Isère, Meylan
| | | | - Anne-Valérie Guizard
- Registre Général des Tumeurs du Calvados, Centre François Baclesse, Caen, France
- U1086 INSERM-UCN "ANTICIPE," Caen, France
| | - Pierre Laurent-Puig
- Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC, Université Paris Descartes, Université Paris Diderot, EPIGENETEC, Paris, France
| | - Claire Mulot
- Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC, Université Paris Descartes, Université Paris Diderot, EPIGENETEC, Paris, France
| | - Julie Guibon
- INSERM, Centre for Research in Epidemiology and Population Health (CESP), 94800 Villejuif, France
- Université Paris-Sud Orsay, Villejuif, France
- Gustave Roussy, Villejuif, France
- Inserm, U900, Institut Curie, Université PSL, Mines ParisTech, Paris, France
| | - Mojgan Karimi
- INSERM, Centre for Research in Epidemiology and Population Health (CESP), 94800 Villejuif, France
- Université Paris-Sud Orsay, Villejuif, France
- Gustave Roussy, Villejuif, France
| | - Martin Schlumberger
- Université Paris-Sud Orsay, Villejuif, France
- Gustave Roussy, Villejuif, France
| | - Elizabeth Adjadj
- INSERM, Centre for Research in Epidemiology and Population Health (CESP), 94800 Villejuif, France
| | - Carole Rubino
- INSERM, Centre for Research in Epidemiology and Population Health (CESP), 94800 Villejuif, France
- Université Paris-Sud Orsay, Villejuif, France
- Gustave Roussy, Villejuif, France
| | - Pascal Guenel
- INSERM, Centre for Research in Epidemiology and Population Health (CESP), 94800 Villejuif, France
- Université Paris-Sud Orsay, Villejuif, France
- Gustave Roussy, Villejuif, France
| | - Jean-Baptiste Cazier
- Institute of Cancer and Genomic Sciences, Centre for Computational Biology, University of Birmingham, Birmingham, UK
| | - Florent de Vathaire
- INSERM, Centre for Research in Epidemiology and Population Health (CESP), 94800 Villejuif, France.
- Université Paris-Sud Orsay, Villejuif, France
- Gustave Roussy, Villejuif, France
| |
Collapse
|